February 10, 2023
Life Sciences
  • The Biden administration released proposed guidance that outlines the first of a pair of major drug price reforms contained in the Inflation Reduction Act. The initial guidance documents for both physician-administered and pharmacy drugs offer details about the formulas that officials plan to use to calculate the penalties, and the process for fines if drugmakers don’t comply. The reforms are projected to save Medicare roughly $170 billion over the next decade. (Press release here; Article here)